Krajewski, Wojciech <br/><br/>
[Genetic and immunologic determinants of intravesical BCG therapy in non-muscle-invasive urothelial bladder cancer].  [electronic resource] 

 -  Postepy higieny i medycyny doswiadczalnej (Online)  Mar 2014 
 - 291-300 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1732-2693 
<br/><br/><label>Standard No.: </label>10.5604/17322693.1094714  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravesical<br/>Antineoplastic Agents--therapeutic use<br/>BCG Vaccine--immunology<br/>Biomarkers, Tumor--urine<br/>Cytokines--biosynthesis<br/>Humans<br/>Immunotherapy<br/>Interleukin-10--urine<br/>Interleukin-2--urine<br/>Neoplasm Recurrence, Local--prevention & control<br/>Survival Rate<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--urine<br/>Urinary Bladder Neoplasms--drug therapy